Syndax Pharmaceuticals

ACRES and Task Force Dagger Foundation Partner to Improve Special Operations Forces Health

The Alliance for Clinical Research Excellence and Safety (ACRES) and the Task Force Dagger Foundation will work together to integrate and advance clinical research and healthcare for all members of the US Special Operations Command CAMBRIDGE MA (PRWEB) JANUARY 09, 2017 Task Force Dagger Foundation (TFD) Managing Director, Keith David, and the Alliance for Clinical Research Excellence and…

ACRES and BSI Launch Global Working Party to Develop Standards for Clinical Research Sites

The Alliance for Clinical Research Excellence and Safety (ACRES), in partnership with the British Standards Institution (BSI), has launched a multi-stakeholder global working party to fast-track development of standards for all aspects of site work, laying the foundation for recognizing and rewarding excellence at clinical research sites worldwide and accelerating development of safe and effective…

Dr. Sandor Kerpel-Fronius Joins ACRES as Vice-President of Global Development

Sandor Kerpel-Fronius, MD, D Sci., joins the Alliance for Clinical Research Excellence and Safety (ACRES) as Vice-President of Global Development. He will lead the development and maintenance of ACRES global outreach activities, overseeing ACRES regional and national entities to improve the conduct of biomedical research worldwide. CAMBRIDGE, MA (PRWEB) JULY 19, 2016 The Alliance for…

ACRES and ActivMed Collaborate on Clinical Research Site Standards and Sustainability

ACRES and ActivMed Collaborate on Clinical Research Site Standards and Sustainability The Alliance for Clinical Research Excellence and Safety (ACRES) and ActivMed Practices & Research, Inc., partner on clinical research site standards, accreditation and training as well as community-based site development programs.   “The creation of a systems-based approach to promote high-performing research sites and…

ACRES and Ethical GmbH, Switzerland to Collaborate on eAdjudication

Ethical GmbH and the Alliance for Clinical Research Excellence and Safety (ACRES) join forces in improving Centralized Endpoint Adjudication – an essential element of drug development. An initial focus is developing standards for Adjudication Committee Charters, standard adjudication workflows and operating procedures to better align these across service providers, sponsors and members of adjudication committees….

Briggs Morrison, CEO, Syndax Pharmaceuticals To Open ACRES Inaugural SYNERGY Event

Dr. Briggs Morrison, CEO of Syndax Pharmaceuticals and previously EVP and Chief Medical Officer at AstraZeneca, to participate in the Alliance for Clinical Research Excellence and Safety’s (ACRES) systems-based event aimed at improving the biomedical research enterprise. CAMBRIDGE, MA (PRWEB) SEPTEMBER 09, 2015 Dr. Briggs Morrison, one of the world’s leading figures in drug development and…